デフォルト表紙
市場調査レポート
商品コード
978923

腸チフスワクチンの世界市場:将来予測 (2027年まで)、ワクチンの種類別 (弱毒生ワクチン、莢膜多糖体ワクチン、複合型ワクチンなど)・投与経路別 (経口薬、注射薬)・地域別の分析、新型コロナウイルス感染症 (COVID-19) の影響

Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, Others); Route of administration (Oral, Injectable), and Geography.

出版日: | 発行: The Insight Partners | ページ情報: 英文 141 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.28円
腸チフスワクチンの世界市場:将来予測 (2027年まで)、ワクチンの種類別 (弱毒生ワクチン、莢膜多糖体ワクチン、複合型ワクチンなど)・投与経路別 (経口薬、注射薬)・地域別の分析、新型コロナウイルス感染症 (COVID-19) の影響
出版日: 2020年10月23日
発行: The Insight Partners
ページ情報: 英文 141 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の腸チフスワクチンの市場規模は、2019年の2億6281万米ドルから、2027年までに5億2532万米ドルにまで拡大する、と予想されています。また、2020年~2027年のCAGRは9.3%と推計されています。

当レポートでは、世界の腸チフスワクチンの市場について分析し、市場の基本構造や背景事情 (主な促進・抑制要因など)、市場規模の動向見通し (今後9年間分)、ワクチンの種類別・投与経路 (RoA) 別・地域別の詳細動向、主要企業のプロファイルと戦略展開状況、昨今の新型コロナウイルス感染症 (COVID-19) に伴う影響、といった情報を取りまとめてお届けいたします。

目次

第1章 イントロダクション

第2章 腸チフスワクチン市場:分析概要

第3章 分析手法

第4章 市場環境

  • 概要
  • PEST分析
  • 専門家の見解

第5章 世界の腸チフスワクチン市場:市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の動向
  • 市場促進・抑制要因の影響度の分析

第6章 腸チフスワクチン市場:世界市場の分析

  • 市場収益額とその予測 (金額ベース、2027年まで)
  • 市場規模の予測と分析:地域別
  • 主要企業の市場ポジショニング

第7章 腸チフスワクチン市場:ワクチンの種類別の分析

  • 概要
  • 腸チフスワクチン市場:ワクチンの種類別シェア (2019年、2027年)
  • 弱毒生ワクチン
  • 莢膜多糖体ワクチン
  • 結合型ワクチン (コンジュゲートワクチン)
  • その他

第8章 腸チフスワクチン市場:投与経路別の分析

  • 概要
  • 腸チフスワクチン市場:投与経路別シェア (2019年、2027年)
  • 経口薬
  • 注射薬

第9章 腸チフスワクチン市場:地域別の分析

  • 北米:腸チフスワクチン市場
  • 欧州:腸チフスワクチン市場
  • アジア太平洋:腸チフスワクチン市場
  • 中東・アフリカ:腸チフスワクチン市場
  • 中南米:腸チフスワクチン市場

第9章 腸チフスワクチン市場:地域別の分析

  • 北米:腸チフスワクチン市場
  • 欧州:腸チフスワクチン市場
  • アジア太平洋:腸チフスワクチン市場
  • 中東・アフリカ:腸チフスワクチン市場
  • 中南米:腸チフスワクチン市場

第10章 世界の腸チフスワクチン市場におけるCOVID-19感染拡大の影響

  • 概要
  • 北米:COVID-19感染拡大の影響度の評価
  • 欧州:COVID-19感染拡大の影響度の評価
  • アジア太平洋:COVID-19感染拡大の影響度の評価
  • 他の国々 (RoW):COVID-19感染拡大の影響度の評価

第11章 業界情勢

  • 概要
  • 各企業が展開した成長戦略
  • 有機的発展
  • 無機的発展

第12章 企業プロファイル

  • Shanghai institute of biological products co., ltd.
  • Paxvax Inc.
  • PT Bio Farma
  • BIO-MED
  • BHARAT BIOTECH
  • Sanofi
  • GlaxoSmithKline plc.
  • Prokarium Ltd.
  • SCANDINAVIAN BIOPHARMA

第13章 付録

図表

List Of Tables

  • Table 1. North America Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 3. US Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 5. Canada Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Canada Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Mexico Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Mexico Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Europe Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 10. Europe Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Germany Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Germany Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 13. UK Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 14. UK Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 15. France Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 16. France Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Spain Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Spain Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Italy Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Italy Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Rest of Europe Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Rest of Europe Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Asia Pacific Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 24. Asia Pacific Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 25. China Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 26. China Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 27. Japan Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 28. Japan Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 29. India Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 30. India Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 31. South Korea Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 32. South Korea Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Australia Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Australia Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Middle East & Africa: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 40. Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 41. UAE: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 42. UAE: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 43. South Africa: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 44. South Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 45. Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 46. Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 47. South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 48. South & Central America: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Brazil: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 50. Brazil: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Argentina: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 52. Argentina: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 53. Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
  • Table 54. Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 55. Organic Developments Done By Companies
  • Table 56. Inorganic Developments Done By Companies
  • Table 57. Glossary of Terms, Typhoid Fever Vaccines Market

List Of Figures

  • Figure 1. Typhoid Fever Vaccines Market Segmentation
  • Figure 2. Typhoid Fever Vaccines Market - By Geography
  • Figure 3. Typhoid Fever Vaccines Market Overview
  • Figure 4. Live Attenuated Vaccine Segment Witness Fastest Growth
  • Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
  • Figure 6. Typhoid Fever Vaccines Market, by Geography (US$ Million)
  • Figure 7. Global Typhoid Fever Vaccines Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Typhoid Fever Vaccines Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East and Africa (MEA) PEST Analysis
  • Figure 13. South and Central America (SCAM) PEST Analysis
  • Figure 14. Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraint
  • Figure 15. Global Typhoid Fever Vaccines Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Typhoid Fever Vaccines Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Typhoid Fever Vaccines Market
  • Figure 18. Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
  • Figure 19. Live Attenuated Vaccine : Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Conjugate Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Others: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
  • Figure 24. Oral: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Injectable: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. North America: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 27. North America Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
  • Figure 28. North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
  • Figure 29. US: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Canada: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 31. Mexico: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 32. Europe: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 33. Europe Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
  • Figure 34. Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
  • Figure 35. Germany: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. UK: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. France: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Spain: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Italy: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Rest of Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 41. Asia Pacific: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 42. Asia Pacific Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
  • Figure 43. China: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Japan: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. India: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. South Korea: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Australia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Rest of Asia-Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Middle East and Africa: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 50. Middle East and Africa: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
  • Figure 52. Saudi Arabia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. UAE: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. South Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Rest of MEA: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 56. South & Central America: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 57. South & Central America: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 58. South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
  • Figure 59. Brazil: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. Argentina: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. Rest of SCAM: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 62. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in North American Countries
  • Figure 63. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in European Countries
  • Figure 64. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Asia Pacific Countries
  • Figure 65. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Rest of the World
  • Figure 66. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00003752

The Typhoid fever vaccines market was valued at US$ million 262.81 in 2019 and is projected to reach US$ 525.32 million by 2027; it is expected to grow at a CAGR of 9.3% from 2020 to 2027.

The growth of the Typhoid fever vaccines market is mainly attributed to factors such as Growing Number of Patients Suffering with Typhoid and Organizations Supporting Typhoid Immunizations. However, the market is likely to get impacted by the risk of side-effects associated with typhoid fever vaccinesduring the forecast period.

Typhoid is known to be the most common fever in rural and underdeveloped economies. According to the recent estimates of the World Health Organization (WHO), typhoid is an endemic fever in Africa, Asia, Latin America, Oceania, and the Caribbean. The WHO also states that 80% of the typhoid fever cases arise from India, Bangladesh, China, Laos, Nepal, Indonesia, Vietnam, and Pakistan. As per the recent study by All India Institute of Medical Sciences (AIIMS), around 494 per 100,000 children of age group 5-15 years suffered from typhoid in 2017.

Various manufacturers and non-government organizations across the world are focused on creating awareness and promoting studies related to the development of new, potent, and innovative vaccines to combat typhoid in patients worldwide. This has led to the development and approvals of a significant number of candidates by the regulatory forces in recent years, which is expected to promote the growth of the typhoid fever vaccine market . The governments of various countries have also come up with strategies and policies to favor the vaccination and immunization campaigns for typhoid fever in their respective countries.

Based on Typhoid fever vaccines Type, the market is segmented into the Typhoid fever vaccines market is segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. In 2019, the capsular polysaccharide vaccines segment accounted for the highest share of the market . Growth of this segment is attributed to the effectiveness associated with in preventing infections and increasing patient pool across the globe. The same segment is likely to register highest CAGR in the global Typhoid fever vaccines market during the forecast period.

Based on route of administrationthe typhoid fever vaccines market is segmented into oral and injections. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR in the market during the forecast period.

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frighteningespecially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase. The World Health Organization and UNICEF warned an alarming decline in the number of children receiving life-saving vaccines around the world. This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic. In 2019, UNICEF procured an estimated 2.43 billion doses of vaccines to around 100 countries to reach around 45% of the world's children below the 5-year-old age group.

The World Health Organization (WHO), Food and Drug Administration (FDA),UNICEF,All India Institute of Medical Sciences, National Health Services, Centers for Disease Control and Prevention, are some of the major primary and secondary sources referred for preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the typhoid fever vaccines market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global typhoid fever vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Typhoid Fever Vaccines Market - By Vaccine Type
    • 1.3.2 Typhoid Fever Vaccines Market - By Route of Administration
    • 1.3.3 Global Typhoid Fever Vaccines Market - By Geography

2. Typhoid Fever Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Typhoid Fever Vaccines- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinions

5. Typhoid Fever Vaccines Market- Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Growing Number of Patients Suffering with Typhoid
    • 5.1.2 Organizations Supporting Typhoid Immunizations
  • 5.2 Market Restraint
    • 5.2.1 Risk of Side-Effects Associated with Typhoid Fever Vaccines
  • 5.3 Market Opportunity
    • 5.3.1 Outsourcing Pharmaceutical Research
  • 5.4 Future Trend
    • 5.4.1 Development of Innovative and Potent Vaccine Candidates
  • 5.5 Impact Analysis

6. Typhoid Fever Vaccines Market - Global Analysis

  • 6.1 Global Typhoid Fever Vaccines Marker Revenue Forecast And Analysis
  • 6.2 Global Typhoid Fever Vaccines Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Typhoid Fever Vaccines Market - By Vaccine Type

  • 7.1 Overview
  • 7.2 Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
  • 7.3 Live Attenuated Vaccine
    • 7.3.1 Overview
    • 7.3.2 Live Attenuated Vaccine : Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Capsular Polysaccharide Vaccines
    • 7.5.1 Overview
    • 7.5.2 Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Conjugate Vaccine
    • 7.6.1 Overview
    • 7.6.2 Conjugate Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

8. Typhoid Fever Vaccines Market Analysis - By Route of Administration

  • 8.1 Overview
  • 8.2 Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
    • 8.2.1 Oral
      • 8.2.1.1 Overview
    • 8.2.2 Oral: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.3 Injectable
    • 8.3.1 Overview
    • 8.3.2 Injectable: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

9. Typhoid Fever Vaccines Market Analysis And Forecast To 2027 - Geographical Analysis

  • 9.1 North America: Typhoid Fever Vaccines Market
    • 9.1.1 Overview
    • 9.1.2 North America: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 9.1.3 North America: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
    • 9.1.4 North America: Typhoid Fever Vaccines Market, by Route of Administration, 2018-2027 (USD Million)
    • 9.1.5 North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
    • 9.1.6 US: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.1 US: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.2 US: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.1.6.3 US: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.1.7 Canada: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.1 Canada: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.2 Canada: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.1.7.3 Canada: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.1.8 Mexico: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.1 Mexico: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.2 Mexico: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.1.8.3 Mexico: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
  • 9.2 Europe: Typhoid Fever Vaccines Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 9.2.3 Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
    • 9.2.4 Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.2.5 Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
    • 9.2.6 Germany: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.1 Germany: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.2 Germany: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.2.6.3 Germany: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.2.7 UK: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.1 UK: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.2 UK: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.2.7.3 UK: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.2.8 France: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.1 France: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.2 France: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.2.8.3 France: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.2.9 Spain: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.1 Spain: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.2 Spain: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.2.9.3 Spain: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.2.10 Italy: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.1 Italy: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.2 Italy: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.2.10.3 Italy: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.2.11 Rest of Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.1 Rest of Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.2 Rest of Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.2.11.3 Rest of Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
  • 9.3 Asia Pacific: Typhoid Fever Vaccines Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 9.3.3 Asia Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
    • 9.3.4 Asia Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.3.5 Asia Pacific: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
    • 9.3.6 China: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.1 China: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.2 China: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.3.6.3 China: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.3.7 Japan: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.1 Japan: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.2 Japan: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.3.7.3 Japan: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.3.8 India: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.1 India: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.2 India: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.3.8.3 India: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.3.9 South Korea: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.1 South Korea: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.2 South Korea: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.3.9.3 South Korea: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.3.10 Australia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.1 Australia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.2 Australia: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.3.10.3 Australia: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
    • 9.3.11 Rest of Asia-Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.11.1 Rest of Asia-Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.11.2 Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
      • 9.3.11.3 Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
  • 9.4 Middle East and Africa: Typhoid Fever Vaccines Market
    • 9.4.1 Overview
    • 9.4.2 Middle East and Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 9.4.3 Middle East and Africa: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
    • 9.4.4 Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 9.4.5 Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
    • 9.4.6 Saudi Arabia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.1 Saudi Arabia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.2 Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.3 Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 9.4.7 UAE: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.1 UAE: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.2 UAE: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.3 UAE: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 9.4.8 South Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.1 South Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.2 South Africa: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.3 South Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 9.4.9 Rest of Middle East & Africa (MEA): Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.9.1 Rest of MEA: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.9.2 Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
      • 9.4.9.3 Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
  • 9.5 South & Central America: Typhoid Fever Vaccines Market
    • 9.5.1 Overview
    • 9.5.2 South & Central America: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
    • 9.5.3 South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
    • 9.5.4 South & Central America: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 9.5.5 South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
    • 9.5.6 Brazil: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.1 Brazil: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.2 Brazil: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.3 Brazil: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 9.5.7 Argentina: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.1 Argentina: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.2 Argentina: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.3 Argentina: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
    • 9.5.8 Rest of SCAM: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.8.1 Rest of SCAM: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.8.2 Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
      • 9.5.8.3 Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Shanghai institute of biological products co., ltd.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Paxvax Inc.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 PT Bio Farma
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 BIO-MED
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 BHARAT BIOTECH
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Sanofi
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 GlaxoSmithKline plc.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Prokarium Ltd.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 SCANDINAVIAN BIOPHARMA
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms